European patent changed to restrict use of embryonic stem cellsBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7358.238/g (Published 03 August 2002) Cite this as: BMJ 2002;325:238
- Annette Tuffs
The so called “Edinburgh” patent–granted to Edinburgh University in cooperation with the Australian firm Stem Cell Sciences in December 1999–has been amended after an outcry from the governments of Germany, Netherlands, and Italy.
The patent covers a …
Log in using your username and password
Log in through your institution
Sign up for a free trial